[go: up one dir, main page]

BG106524A - Piperidine quinolyl propyl derivatives and their use as antibacterial means - Google Patents

Piperidine quinolyl propyl derivatives and their use as antibacterial means

Info

Publication number
BG106524A
BG106524A BG106524A BG10652402A BG106524A BG 106524 A BG106524 A BG 106524A BG 106524 A BG106524 A BG 106524A BG 10652402 A BG10652402 A BG 10652402A BG 106524 A BG106524 A BG 106524A
Authority
BG
Bulgaria
Prior art keywords
piperidine
quinolyl propyl
antibacterial means
propyl derivatives
hydrogen
Prior art date
Application number
BG106524A
Other languages
Bulgarian (bg)
Inventor
Jean-Luc Malleron
Michel Tabart
Jean-Christophe Carry
Michel Evers
Ahmad Youssef El
Serge Mignani
Fabrice Viviani
Michel Cheve
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of BG106524A publication Critical patent/BG106524A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

The synthesized compounds are used as active substances for producing means for the treatment of primary bacterial infections. The quinolyl propyl piperidine derivatives have the general formula wherein R1 is hydrogen or halogen atom or hydroxy radical, R'1 is hydrogen atoms or may also mean halogen when R1 is also a halogen atom, Ro is a hydrogen atom, and the meanings of R2, R3 and R4 are given in the description. 11 claims
BG106524A 1999-09-17 2002-03-15 Piperidine quinolyl propyl derivatives and their use as antibacterial means BG106524A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911679A FR2798656B1 (en) 1999-09-17 1999-09-17 DERIVATIVES OF QUINOLYL PROPYL PIPERIDINE, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
PCT/FR2000/002541 WO2001025227A2 (en) 1999-09-17 2000-09-14 Quinolyl propyl piperidine derivatives and their use as antibacterial agents

Publications (1)

Publication Number Publication Date
BG106524A true BG106524A (en) 2003-01-31

Family

ID=9549990

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106524A BG106524A (en) 1999-09-17 2002-03-15 Piperidine quinolyl propyl derivatives and their use as antibacterial means

Country Status (30)

Country Link
EP (2) EP1484328B1 (en)
JP (1) JP2004527448A (en)
KR (1) KR20020038757A (en)
CN (1) CN1374959A (en)
AP (1) AP2002002459A0 (en)
AT (1) ATE284399T1 (en)
AU (1) AU7429500A (en)
BG (1) BG106524A (en)
BR (1) BR0014060A (en)
CA (1) CA2383836A1 (en)
CZ (1) CZ2002940A3 (en)
DE (2) DE60016611T2 (en)
DZ (1) DZ3195A1 (en)
EA (1) EA005183B1 (en)
EE (1) EE200200138A (en)
FR (1) FR2798656B1 (en)
GE (1) GEP20043223B (en)
HR (1) HRP20020214A2 (en)
HU (1) HUP0204283A3 (en)
IL (1) IL148720A0 (en)
MA (1) MA26820A1 (en)
MX (1) MXPA02001979A (en)
NO (1) NO20021253L (en)
OA (1) OA12022A (en)
PL (1) PL354809A1 (en)
SK (1) SK3632002A3 (en)
TN (1) TNSN00184A1 (en)
WO (1) WO2001025227A2 (en)
YU (1) YU19002A (en)
ZA (1) ZA200202073B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
JP2004504397A (en) 2000-07-26 2004-02-12 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー Aminopiperidinequinolines with antibacterial activity and their azaisosteric analogs
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
US7109213B2 (en) 2002-01-29 2006-09-19 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
JP4445753B2 (en) 2002-01-29 2010-04-07 グラクソ グループ リミテッド Aminopiperidine derivatives
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
FR2842807A1 (en) * 2002-07-23 2004-01-30 Aventis Pharma Sa QUINOLYL PROPYL PIPERIDINE DERIVATIVES, PROCESS AND PREPARATION INTERMEDIATES AND COMPOSITIONS COMPRISING THE SAME
FR2844270B1 (en) * 2002-09-11 2006-05-19 Aventis Pharma Sa QUINOLYL PROPYL PIPERIDINE DERIVATIVES, THEIR PROCESS AND PREPARATION INTERMEDIATES AND THE COMPOSITIONS CONTAINING THEM
FR2844268B1 (en) * 2002-09-11 2004-10-22 Aventis Pharma Sa QUINOLYL PROPYL PIPERIDINE DERIVATIVES, PROCESSES AND INTERMEDIATES FOR THEIR PREPARATION, AND COMPOSITIONS CONTAINING THEM
EP2239260A1 (en) * 2002-10-10 2010-10-13 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Novel compounds with antibacterial activity
WO2004096982A2 (en) 2002-11-05 2004-11-11 Smithkline Beecham Corporation Antibacterial agents
ES2350977T3 (en) 2002-11-05 2011-01-28 Glaxo Group Limited ANTIBACTERIAL AGENTS.
AU2003294565A1 (en) 2002-12-04 2004-06-23 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
EP1799674B1 (en) * 2004-10-05 2010-05-05 Actelion Pharmaceuticals Ltd. New piperidine antibiotics
WO2006038172A1 (en) * 2004-10-05 2006-04-13 Actelion Pharmaceuticals Ltd New piperidine antibiotics
WO2006081178A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
US7605169B2 (en) 2005-01-25 2009-10-20 Glaxo Group Limited Antibacterial agents
JP2008528587A (en) 2005-01-25 2008-07-31 グラクソ グループ リミテッド Antibacterial agent
US7592334B2 (en) 2005-01-25 2009-09-22 Glaxo Group Limited Antibacterial agents
ATE536351T1 (en) 2006-01-26 2011-12-15 Actelion Pharmaceuticals Ltd TETRAHYDROPYRAN ANTIBIOTICS
US7709483B2 (en) 2006-04-06 2010-05-04 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
CN101679357A (en) * 2007-05-09 2010-03-24 辉瑞大药厂 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
ES2561631T3 (en) 2009-01-15 2016-02-29 Glaxo Group Limited Naphthyridine-2 (1H) -one compounds useful as antibacterial agents
ES2670550T3 (en) * 2013-10-14 2018-05-30 Eisai R&D Management Co., Ltd. Selectively substituted quinoline derivatives
AU2015304847B2 (en) 2014-08-22 2018-10-25 Glaxosmithkline Intellectual Property Development Limited Tricyclic nitrogen containing compounds for treating Neisseria gonorrhoea infection
UY36851A (en) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd COMPOUNDS FOR USE IN ANTIBACTERIAL APPLICATIONS
EP3390389B1 (en) 2015-12-17 2021-05-19 Merck Patent GmbH Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
CA3033240A1 (en) 2016-08-08 2018-02-15 Merck Patent Gmbh Tlr7/8 antagonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69908555T2 (en) * 1998-01-26 2004-05-06 Smithkline Beecham P.L.C., Brentford CHINOLINE DERIVATIVES AS AN ANTIBACTERIAL MEDICINAL PRODUCT
WO2000043383A1 (en) * 1999-01-20 2000-07-27 Smithkline Beecham P.L.C. Piperidinylquinolines as protein tyrosine kinase inhibitors

Also Published As

Publication number Publication date
OA12022A (en) 2006-04-19
AU7429500A (en) 2001-05-10
DE60034713T2 (en) 2008-01-17
IL148720A0 (en) 2002-09-12
FR2798656A1 (en) 2001-03-23
MA26820A1 (en) 2004-12-20
WO2001025227A2 (en) 2001-04-12
EP1484328B1 (en) 2007-05-02
GEP20043223B (en) 2004-04-26
YU19002A (en) 2005-06-10
TNSN00184A1 (en) 2005-11-10
DE60034713D1 (en) 2007-06-14
EA005183B1 (en) 2004-12-30
EP1218370A2 (en) 2002-07-03
EA200200374A1 (en) 2002-10-31
CN1374959A (en) 2002-10-16
HUP0204283A3 (en) 2004-07-28
FR2798656B1 (en) 2004-12-17
KR20020038757A (en) 2002-05-23
CA2383836A1 (en) 2001-04-12
MXPA02001979A (en) 2002-08-20
HUP0204283A2 (en) 2003-04-28
JP2004527448A (en) 2004-09-09
NO20021253D0 (en) 2002-03-13
BR0014060A (en) 2002-05-21
NO20021253L (en) 2002-04-24
DE60016611D1 (en) 2005-01-13
EE200200138A (en) 2003-06-16
SK3632002A3 (en) 2003-04-01
WO2001025227A3 (en) 2001-11-22
EP1218370B1 (en) 2004-12-08
EP1484328A1 (en) 2004-12-08
CZ2002940A3 (en) 2002-07-17
DZ3195A1 (en) 2001-04-12
AP2002002459A0 (en) 2002-06-30
ATE284399T1 (en) 2004-12-15
PL354809A1 (en) 2004-02-23
DE60016611T2 (en) 2005-12-22
HRP20020214A2 (en) 2005-04-30
ZA200202073B (en) 2003-08-27

Similar Documents

Publication Publication Date Title
BG106524A (en) Piperidine quinolyl propyl derivatives and their use as antibacterial means
AU674477B2 (en) Heterocyclic-cyclic amine derivatives
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
AU2002216214A1 (en) Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
BG103947A (en) Derivatives of 9-oxymerythromycin
DE69923849D1 (en) QUINOLIN-2-ON DERIVATIVES USE AS ANTICROPHOSIS
GB9917408D0 (en) Compounds
MY137156A (en) Dual nk1/nk3 derivatives
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
NO20015172L (en) 1-methyl-erythromycin derivatives
CA2146763A1 (en) Quinolone and acridinone derivatives for the treatment of urinary incontinence
PL358666A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
DE69907419D1 (en) Antitumorwirkstoffe
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
BG105004A (en) Carbapenem derivatives, utilization thereof and intermediate compounds of the same
NO20022123L (en) Oxoxazole derivatives for use as inhibitors of phosphodiesterase VII
EP1121932A4 (en) Remedies for ocular diseases
CA2374902A1 (en) Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation
YU46302A (en) Substituted pyrroles
AP9801235A0 (en) Erythromycin derivatives.
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use